Cytek Biosciences, Inc. announced that Patrik Jeanmonod has been appointed as the company?s head of corporate development analytics. Jeanmonod served as Cytek?s chief financial officer since 2018.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.34 USD | +2.26% | +1.85% | -30.54% |
05-08 | Earnings Flash (CTKB) CYTEK BIOSCIENCES Reports Q1 Revenue $44.9M, vs. Street Est of $43.6M | MT |
05-08 | Transcript : Cytek Biosciences, Inc., Q1 2024 Earnings Call, May 08, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.54% | 814M | |
+11.17% | 221B | |
+8.95% | 186B | |
+14.65% | 137B | |
+27.59% | 109B | |
-0.04% | 63.09B | |
+13.91% | 52.68B | |
+4.86% | 50.86B | |
+7.66% | 42.53B | |
+7.23% | 37.76B |
- Stock Market
- Equities
- CTKB Stock
- News Cytek Biosciences, Inc.
- Cytek Biosciences, Inc. Announces Appointment of Patrik Jeanmonod as Head of Corporate Development Analytics